Sort   by:  
 Page size 
UnknownPerioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial.
Not available
S-EPMC11519011 | biostudies-literature
UnknownBlood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial.
Not available
S-EPMC8288017 | biostudies-literature
UnknownPredictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study.
Not available
S-EPMC6737207 | biostudies-literature
UnknownDaclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme.
Not available
S-EPMC5600115 | biostudies-literature
GenomicsGenome-wide analysis of FNR and M-OM-^C70 in E. coli under aerobic and anaerobic growth conditions.
We found many binding sites for FNR under glucose fermentative anaerobic growth conditions. Also, many binding sites were identified for M-OM-^C70 under both aerobic and anaerobic growthin conditions. Descirbed in the manuscript "Genome-scale Analysis of E. coli FNR Reveals the Complexity of B...
ORGANISM(S): Escherichia coli str. K-12 substr. MG1655 
2013-06-20 | E-GEOD-41187 | biostudies-arrayexpress
UnknownCardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.
Not available
S-EPMC5675358 | biostudies-literature
UnknownClinical Characteristics of Acute Hepatitis E and Their Correlation with HEV Genotype 3 Subtypes in Italy.
Not available
S-EPMC7650787 | biostudies-literature
UnknownNeoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.
Not available
S-EPMC9844511 | biostudies-literature
ProteomicsThe Parkinson's disease protein alpha-synuclein is a direct modulator of Processing-bodies and mRNA stability
Hallacli E, Kayatekin C, Nazeen S, Wang XH, Sheinkopf Z, Sathyakumar S, Sarkar S, Jiang X, Dong X, Di Maio R, Wang W, Keeney MT, Felsky D, Sandoe J, Vahdatshoar A, Udeshi ND, Mani DR,Carr SA, de Jager P, Myers CL, Lindquist S, Greenmyre TJ, Bartel DP, Feany MB, Sunyaev S, Chung CY and Khurana V. Alp...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2022-03-09 | MSV000089026 | MassIVE
UnknownRelatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.
Not available
S-EPMC9844513 | biostudies-literature
Sort   by:  
 Page size